BMJ 2001;322:577 ( 10 March )

Papers

Comparison of elderly people's technique in using two dry powder inhalers to deliver zanamivir: randomised controlled trial

Paul Diggory, consultant, ^a Christophe Fernandez, coordinator of medical audit, ^b Amanda Humphrey, specialist registrar, ^a Valerie Jones, consultant, ^a Maeve Murphy, specialist registrar. ^a

^a Department of Elderly Care Medicine, Mayday Hospital, Croydon CR7 7YE, ^b Department of Clinical Audit, Mayday Hospital

Correspondence to: P Diggory Pdiggory{at}aol.com

Objective: To determine whether elderly people can learn to use the inhaler used to deliver zanamivir (Relenza Diskhaler) as effectively as the Turbohaler and to identify which aspects of inhaler technique are most problematic.
Design: Randomised, controlled, intervention study.
Setting: Wards for acute elderly care in a large district general hospital.
Participants: 73 patients who were unfamiliar with the use of an inhaler, aged 71 to 99 (mean 83) years.
Main outcome measures: Initial scores and changes in scores 24 hours later using a 10 point scoring system of five aspects of inhaler technique.
Results: 38 patients were allocated the Relenza Diskhaler and 35 the Turbohaler. The mean total score was significantly greater in the Turbohaler than Diskhaler groups both initially (8.74 v 7.05) and after 24 hours (8.28 v 5.43). The major difference between inhalers was in loading and priming. After tuition 50% (19 of 38) of patients allocated the Diskhaler were unable to load and prime the device and 65% (24 of 37) were unable to do so 24 hours later. Of those allocated the Turbohaler, two patients were unable to load and prime the device after initial review and one after 24 hours.
Conclusion: Most elderly people cannot use the inhaler device used to deliver the anti-influenza drug zanamivir. Treatment with this drug is unlikely to be effective in elderly people unless the delivery system is improved.

---

© BMJ 2001
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Elderly people's technique in using dry powder inhalers

Lindsey Dow, L Fowler, H Lamb, and G H Hall
BMJ 2001 323: 49. [Extract] [Full Text]

Delivering drugs and making the BMJ less boring
BMJ 2001 322: 0. [Full Text] [PDF]

Delivering drugs and making the BMJ less boring
BMJ 2001 322: 0. [Full Text] [PDF]

Elderly people are unlikely to benefit from zanamivir treatment because of the delivery system
BMJ 2001 322: 0. [Full Text]

This article has been cited by other articles:

• Khazeni, N., Bravata, D. M., Holty, J.-E. C., Uyeki, T. M., Stave, C. D., Gould, M. K. (2009). Systematic Review: Safety and Efficacy of Extended-Duration Antiviral Chemoprophylaxis Against Pandemic and Seasonal Influenza. ANN INTERN MED 151: 464-473 [Abstract] [Full text]  
• Mossad, S. B. (2009). Influenza in long-term care facilities: Preventable, detectable, treatable. Cleveland Clinic Journal of Medicine 76: 513-521 [Abstract] [Full text]  
• Janssens, W., VandenBrande, P., Hardeman, E., De Langhe, E., Philps, T., Troosters, T., Decramer, M. (2008). Inspiratory flow rates at different levels of resistance in elderly COPD patients. Eur Respir J 31: 78-83 [Abstract] [Full text]  
• Jarvis, S., Ind, P. W., Shiner, R. J. (2007). Inhaled therapy in elderly COPD patients; time for re-evaluation?. Age Ageing 36: 213-218 [Abstract] [Full text]  
• Rothberg, M. B., Bellantonio, S., Rose, D. N. (2003). Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy. ANN INTERN MED 139: 321-329 [Abstract] [Full text]  
• Allen, S C, Ragab, S (2002). Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad. Med. J. 78: 37-39 [Abstract] [Full text]  
• (2001). Other Articles Noted. Evid. Based Nurs. 4: E1-11 [Full text]  
• Dow, L., Fowler, L, Lamb, H, Hall, G H (2001). Elderly people's technique in using dry powder inhalers. BMJ 323: 49-49 [Full text]  
• (2001). The Elderly and Inhalers: Device Type Makes a Difference. JWatch General 2001: 6-6 [Full text]  

Rapid Responses:

Read all Rapid Responses

Elderly people's use of dry powder inhalers: where was the connection with Influenza?

Andrew Martin
bmj.com, 9 Mar 2001 [Full text]

Which inhaler device ? Which patient ?

Jonathan Bell
bmj.com, 9 Mar 2001 [Full text]

Zanamavir and Unreason

G H Hall
bmj.com, 10 Mar 2001 [Full text]

Re: Elderly people's use of dry powder inhalers: where was the connection with Influenza?

Paul Diggory, et al.
bmj.com, 12 Mar 2001 [Full text]

New Inhaler devices infrequently used by older people in the community

Lindsey Dow
bmj.com, 18 Mar 2001 [Full text]

Competing interests - a comment to the Turbuhaler Diskhaler influenza article

Lars Borgström
bmj.com, 19 Mar 2001 [Full text]

Dry powder inhaler and elderly patients

Dominique Vanpee
bmj.com, 21 Mar 2001 [Full text]

Re: Competing interests - Professor Borgstrom's comments, or AstraZeneca's defence of Turbohaler ?

Jonathan Bell
bmj.com, 9 Apr 2001 [Full text]

Online poll

Find out more >>